103 related articles for article (PubMed ID: 27221864)
1. Effects of SULT1A1 Copy Number Variation on Estrogen Concentration and Tamoxifen-Associated Adverse Drug Reactions in Premenopausal Thai Breast Cancer Patients: A Preliminary Study.
Charoenchokthavee W; Ayudhya DP; Sriuranpong V; Areepium N
Asian Pac J Cancer Prev; 2016; 17(4):1851-5. PubMed ID: 27221864
[TBL] [Abstract][Full Text] [Related]
2. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
3. SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen.
Moyer AM; Suman VJ; Weinshilboum RM; Avula R; Black JL; Safgren SL; Kuffel MJ; Ames MM; Ingle JN; Goetz MP
Pharmacogenomics; 2011 Nov; 12(11):1535-43. PubMed ID: 21961651
[TBL] [Abstract][Full Text] [Related]
4. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
[TBL] [Abstract][Full Text] [Related]
5. Relationship of SULT1A1 copy number variation with estrogen metabolism and human health.
Liu J; Zhao R; Ye Z; Frey AJ; Schriver ER; Snyder NW; Hebbring SJ
J Steroid Biochem Mol Biol; 2017 Nov; 174():169-175. PubMed ID: 28867356
[TBL] [Abstract][Full Text] [Related]
6. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
[TBL] [Abstract][Full Text] [Related]
7. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.
Sillanpää P; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K; Hirvonen A
Pharmacogenet Genomics; 2005 Oct; 15(10):749-52. PubMed ID: 16141802
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
9. Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Singh M; Zhou X; Chen X; Santos GS; Peuget S; Cheng Q; Rihani A; Arnér ESJ; Hartman J; Selivanova G
Breast Cancer Res; 2020 Jul; 22(1):80. PubMed ID: 32727562
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy.
Sanchez-Spitman AB; Dezentjé VO; Swen JJ; Moes DJAR; Gelderblom H; Guchelaar HJ
Breast Cancer Res Treat; 2018 Nov; 172(2):401-411. PubMed ID: 30120701
[TBL] [Abstract][Full Text] [Related]
11. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
Seth P; Lunetta KL; Bell DW; Gray H; Nasser SM; Rhei E; Kaelin CM; Iglehart DJ; Marks JR; Garber JE; Haber DA; Polyak K
Cancer Res; 2000 Dec; 60(24):6859-63. PubMed ID: 11156380
[TBL] [Abstract][Full Text] [Related]
12. Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones.
Yang G; Gao YT; Cai QY; Shu XO; Cheng JR; Zheng W
Breast Cancer Res Treat; 2005 Nov; 94(1):63-70. PubMed ID: 16175316
[TBL] [Abstract][Full Text] [Related]
13. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
Wegman P; Vainikka L; Stål O; Nordenskjöld B; Skoog L; Rutqvist LE; Wingren S
Breast Cancer Res; 2005; 7(3):R284-90. PubMed ID: 15987423
[TBL] [Abstract][Full Text] [Related]
14. Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women.
Moyer AM; de Andrade M; Weinshilboum RM; Miller VM
Menopause; 2016 Aug; 23(8):863-9. PubMed ID: 27300114
[TBL] [Abstract][Full Text] [Related]
15. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1.
Aust S; Jaeger W; Klimpfinger M; Mayer K; Baravalle G; Ekmekcioglu C; Thalhammer T
J Pineal Res; 2005 Oct; 39(3):276-82. PubMed ID: 16150108
[TBL] [Abstract][Full Text] [Related]
18. SULT1A1 copy number variation: ethnic distribution analysis in an Indian population.
Almal S; Padh H
Ann Hum Biol; 2017 Nov; 44(7):663-666. PubMed ID: 28875717
[TBL] [Abstract][Full Text] [Related]
19. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
